Life + Career Osteopathic Research OMED Research Track

OMED Research Track

Research track

Research opportunities abound at OMED

The AOA Research Focus Track features cutting-edge speakers and an informative poster session/competition.

Join us each year at OMED for the AOA Research Focus Track, which features dynamic presentations from osteopathic researchers, research abstracts, and an informative and enlightening poster session. OMED 2018 will be held Oct. 5-9 in San Diego.


Present a research poster

New and seasoned researchers will participate in the OMED poster session, which includes a student poster competition co-hosted by SOMA. Abstract submission is now closed for OMED 2018.


Learn from expert researchers

Be sure to check out an interactive research workshop for all levels of researchers from 1:30 to 5 p.m. Saturday, Oct. 6, during OMED. The workshop is presented by the Student Osteopathic Medical Association, the Bureau of Scientific Affairs and Public Health and The Journal of the American Osteopathic Association.

The panel of clinical, population health and basic science research experts will present their best research planning and execution practices. During the workshop, you can learn about the research and publishing process as well as receive advice from a research professional on existing or future projects.

You can take advantage of this unique opportunity to have experts review your project details and discuss them during the workshop and/or privately by filling out the Project Proposal Form by Friday, Sept. 14.


OMED 18 Research dissemination speakers

Atopic dermatitis: New and old treatment updates | Shan Shan Wu, DO, AOCAI

Shan Shan Wu, DOAtopic dermatitis is a common malady of the young, although it may also affect adults. Control of its triggers, such as itch, food, irritants, dryness, infection and etc., may minimize the symptoms (Geoghegan, 2017). Defects of skin structures predispose the patients to atopic dermatitis. Typical treatments that have been used for years are well known by parents, grandparents, and practitioners (Powell, 2018). Although helpful in mild types, the more severe have been problematic. Newer biologicals have been exceedingly helpful in the treatment and relief of bothersome symptoms (Davis, 2018). This discussion will review all aspects of old and new therapies in the treatment of atopic dermatitis.

View Bios

View Presentations

Atopic and contact skin disease | Neha Sanan, DO, AOCAI

Neha Sanan, DOUrticaria and angioedema are a group of skin conditions that may occur together or individually (Maxim, 2018). Their causation may be the same or dramatically different. Treatment can vastly be different depending on the etiology of the disorder (Dressler, 2018). The more acute events may have a trigger. The more chronic events may have an idiopathic dilemma. Despite the nature of the process, the differential diagnosis is often muddied by physicians, therefore making the effective treatment of the patient delayed. With the appropriate historical ques, appropriate treatment may be initiated. We will discuss the appropriate question algorithm, followed by treatment. Biological therapy will be discussed within each diagnosis (Saco, 2018).

View Bios

View Presentations

Advanced neuroimaging in concussion translational collaboration | David Baron, MSEd, DO, ACONP

David Baron, MSEd, DOSports concussion occur in over 3.8 million youth every year. Concussions occur in many youths not involved in organized sports programs. Physically abused, bullied, and youths with other neuropsychiatric disorders are at increased risk to sustain concussions that never get reported or clinically evaluated. Mild, repetitive concussions can affect cognitive, emotional and behavioral functioning acutely and after the initial injury. To date, there are no definitive diagnostic assessment tools or reliable biomarkers. Clinicians need to be knowledgeable of current diagnostic criteria and management tools to better evaluate and treat these patients. Advanced neuroimaging holds promise, but needs to be carefully evaluated as a clinical tool.

View Bios

View Presentations

Controlling drugs or people? The history of drug policy in America | Amanda Reiman. PhD, MSW, AOCOPM

Amanda Reiman. PhD, MSWDrugs were not always illegal in America. There was a time when a person could obtain a prescription for cocaine, heroin, and amphetamine from their physician. However, in 1914 all of that changed with The Harrison Act, the first federal drug law that made it illegal for physicians to prescribe drugs simply due to their patient’s dependence on it. Overnight an illicit drug market and associated culture was born. And, after that, the U.S. would engage in “war” on those who did not have the privilege to obtain drugs from private sources. While the media has focused on various “drug epidemics” over the years, this session will focus on the underlying goals associated with these laws and the handling of drug issues in the U.S.

View Bios

View Presentations

Addressing the opioid epidemic with cannabis | Amanda Reiman. PhD, MSW, AOCOPM

Amanda Reiman. PhD, MSWAccidental overdose of opiates is now the leading cause of accidental death in the U.S. In America, we comprise 25% of the world’s population and consume 99% of the world’s hydrocodone. As far back as 1889, doctors have been exploring the use of cannabis for opiate dependence. A sharp increase in opiate fatalities coupled with the population most impacted has regulators, researchers and others looking for novel approaches, including cannabis. This session will focus on three points at which cannabis can interface with opiates to encourage harm reduction: as a first line defense for pain, as a withdrawal medication, and as a maintenance medication to prevent relapse. Research in the area of cannabis and harm reduction will be presented.

View Bios

View Presentations

Impact of OMM on Parkinson’s Disease: Lessons learned and future directions | Sheldon Yao, DO, AAO

Sheldon Yao, DOThis presentation will focus on the development of our research study, which was funded by the AOA in September 2016 to investigate the effects of OMM on Parkinson’s Disease motor function and biomarkers. In sharing the challenges and accomplishments from the study, we hope that the audience will gain an appreciation of osteopathic research and learn how they can participate and learn from the challenges we faced. The presentation will focus on Parkinson’s disease and how OMM can potentially help our subjects with movement. We will share the results of our studies examining the potential mechanism of OMM and integrating translation research. Finally, we will have a hands-on session where participants will learn to apply our PARK-OMM protocol used in the study.

View Bios

View Presentations

Addressing Health Disparities at a Student-Run Free Clinic and Research Opportunities | Melissa G. Pearce, DO, AAO

Melissa G. Pearce, DOSeveral schools and colleges of osteopathic medicine have established student run free clinics, which provide health care for a variety of populations. Some of these clinics serve the institution’s community of employees and students, but some also aim to serve the local community, especially those who are underserved. This session explores one such clinic at Touro University California, including research efforts, such as assessing whether the clinic is serving its target population, organizing outcomes analysis of new programs, and implementation of the RIOT (Reducing Inflammation with Osteopathic Treatment) study in this venue.

View Bios

View Presentations

Back To Top